STAT April 15, 2021
Katie Palmer

For the 1.6 million people in America living with type 1 diabetes, a continuous glucose monitor can be a lifesaver.

Since the first CGM was approved by the Food and Drug Administration in 1999, the diabetes community has advocated for lower prices and better insurance coverage for the quarter-sized devices, which regularly sample a proxy for blood glucose levels and can sound an alarm when they swing too high or too low. The cost-cutting has had an unexpected side effect: Today, glucose monitors are so cheap they’ve spawned a new crop of digital health startups selling the devices to consumers, many of whom don’t have diabetes.

Glucose monitors are only approved in the U.S. for use in people with diabetes...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Digital Health, Patient / Consumer, Provider, Technology, Wearables
How Remote Patient Monitoring and AI Personalize Care
Digital Platforms Streamline Medication Access and Delivery
Too much data? Wearables for senior care have value but providers must know how to parse their output, experts say
Novel tech to answer nature’s call: Smartphone app provides real-time bladder data for seniors who need assistance
25 best healthcare software companies, per Healthcare Technology Report

Share This Article